RNA-Seq reveals a novel therapeutic strategy for ALS treatment

December 12, 2017 Leave a comment 4,168 Views

Amyotrophic lateral sclerosis (ALS) is a fatal heterogeneous neurodegenerative disease that lacks effective treatment option. Researchers at Genervon Biopharmaceuticals hypothesized that the traditional single-target approach to treat neurodegenerative...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Genervon Biopharmaceuticals

RNA-Seq reveals a novel therapeutic strategy for ALS treatment

MATQ_Drop – Multiple-Annealing-and-Tailing-based Quantitative scRNA-seq in Droplets

Featured RNA-Seq Job – Research Technician II – Single Cell RNA Sequencing

IMMUcan scDB – a fully integrated scRNA-seq database exclusively dedicated to human cancer

Correspondence analysis for dimension reduction, batch integration, and visualization of single-cell RNA-seq data

Mutant KRAS signaling drives alternative splicing in lung cancer cells

Single cell RNA-sequencing identifies cause for loss of smell in long COVID patients

ESPRESSO – robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data